Crisscrossing the Iron Curtain. Clinical Trials in the German Democratic Republic, 1983-1990

Pascal Grosse

Revue d'études comparatives Est-Ouest, 2018, vol. N° 1, issue 1, 95-125

Abstract: This paper examines the history of the clinical trials conducted in the German Democratic Republic (GDR) mandated by Western pharmaceutical companies between 1983 and 1990. Beginning in 2010, that history was hotly debated in the German media. The paper argues that a centralised state health care system like that in the GDR corresponded better to the requirements of the international pharmaceutical industry for clinical trials than did a privately organised and more decentralised health care system. It was perhaps less the coercive nature of the Eastern German State that was attractive to Western companies, than an effectively centralised health care system. Whatever the case, the arrangement permitted a win-win situation for both partners during the times of the ?Cold War.?

Keywords: German Democratic Republic; Federal Republic of Germany; clinical trials; pharmaceutical industry; drugs; centralised health care system; clinical research organisation (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=RECEO1_491_0095 (application/pdf)
http://www.cairn.info/revue-d-etudes-comparatives-est-ouest-2018-1-page-95.htm (text/html)
free

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:recpuf:receo1_491_0095

Access Statistics for this article

More articles in Revue d'études comparatives Est-Ouest from Presses Universitaires de France
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().